AI startup Lunit's 3D breast cancer screening tech hits U.S.
Korean medical startup Lunit’s AI-powered cancer diagnosis product Lunit Insight DBT is now commercially available in the United States after securing its first supply deal, two months after the U.S. Food and Drug Administration (FDA) approved it.